AAMI TIR100-2021 PDF

Full title and description

AAMI TIR100:2021 — End-to-end microbiological quality and sterility assurance. This Technical Information Report (TIR) provides guidance for a comprehensive framework that integrates and connects Microbiological Quality and Sterility Assurance (MQ&SA) into an organization’s end-to-end process for the development, validation, and routine control of sterile health care products.

Abstract

AAMI TIR100:2021 describes a systems-level approach to assure microbiological quality and sterility across the full product lifecycle: from design inputs and manufacturing controls through sterilization process selection, validation, packaging, release testing, and post-market surveillance. The TIR emphasizes risk-based integration of microbiological controls (bioburden, microbial characterization) with sterilization assurance activities and quality systems to support consistent delivery of sterile healthcare products.

General information

• Status: Current / Active.
• Publication date: Approved by AAMI October 1, 2021 (AAMI approval); published/issued May 10, 2022 (commercial publication listings).
• Publisher: Association for the Advancement of Medical Instrumentation (AAMI).
• ICS / categories: 07.100 — Microbiology; 11.080 — Sterilization and disinfection.
• Edition / version: 2021 edition (TIR100:2021).
• Number of pages: 27 pages.

Scope

The report provides guidance for integrating Microbiological Quality & Sterility Assurance (MQ&SA) activities across an organization’s end-to-end product lifecycle for sterile healthcare products. Scope includes defining MQ&SA requirements during research and development, bioburden characterization and control, selection and validation of sterilization methods, routine process control and release, sterile barrier systems, and post-market considerations. The TIR is intended for single‑use/terminally‑sterilized products; reusable device processing is not the primary focus although the principles for design, verification and validation are generally applicable.

Key topics and requirements

• End-to-end MQ&SA framework linking R&D, manufacturing, sterilization, packaging, and post-market feedback.
• Design inputs and requirements to ensure product is compatible with intended sterilization approach.
• Bioburden assessment, microbial characterization, and bioburden control strategies.
• Selection, development, validation, and routine control of sterilization processes (EO, radiation, steam, etc.).
• Sterile barrier system and packaging considerations to maintain sterility through distribution and use.
• Process monitoring, validation data requirements, and product release principles.
• Integration of risk management (ISO 14971 principles) into MQ&SA decision making.
• Post-market surveillance, complaint handling, and change control as they affect sterility assurance.

Typical use and users

Primary users are medical device manufacturers (design, sterilization and quality/RA teams), sterilization service providers, contract sterilizers, sterilization validation specialists, sterile processing and QA personnel, regulatory reviewers, and consultants working on sterility assurance and microbiological quality for healthcare products.

Related standards

TIR100 is intended to complement other AAMI and ISO standards on sterilization and microbiological methods — for example ISO/ANSI/AAMI sterilization series and microbiological-method documents (ISO 11137 radiation sterilization series, ISO 11737 series for bioburden and sterility testing), AAMI ST67 (selecting a sterility assurance level), AAMI ST79 (steam sterilization guidance), and related AAMI TIRs on sterilization and microbiological methods. These related documents are commonly referenced together when developing sterilization and sterility-assurance strategies.

Keywords

sterility assurance, microbiological quality, MQ&SA, sterilization validation, bioburden, sterile barrier system, packaging, sterilization process control, medical device sterilization, risk management, AAMI TIR100

FAQ

Q: What is this standard?

A: AAMI TIR100:2021 is a Technical Information Report offering guidance for an integrated, end-to-end approach to microbiological quality and sterility assurance for sterile healthcare products.

Q: What does it cover?

A: It covers the lifecycle activities that affect microbiological quality and sterility — from design inputs and bioburden control through sterilization method selection, validation and routine control, packaging/sterile barrier considerations, release, and post-market feedback.

Q: Who typically uses it?

A: Medical device manufacturers (R&D, manufacturing, QA/RA), contract sterilizers, sterilization validation engineers, sterile processing professionals, and regulatory or auditing personnel.

Q: Is it current or superseded?

A: As of the date of this product page it is listed as the current AAMI TIR100:2021 edition (approved October 1, 2021; commercially published in listings in 2022). Users should verify status before use because standards can be reaffirmed, revised, or superseded; AAMI maintains the authoritative status and update history.

Q: Is it part of a series?

A: Yes — TIR100 is one of several AAMI TIRs and related AAMI/ANSI/ISO standards addressing sterilization, microbiological methods, and sterility assurance. It is frequently used alongside the ISO/AAMI sterilization and microbiological standards mentioned above.

Q: What are the key keywords?

A: sterility assurance; microbiological quality; bioburden; sterilization validation; sterile barrier; packaging; process control; medical device sterilization; risk management; AAMI.